These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27088514)

  • 21. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
    Skryabin VY; Vinnikova MA
    J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Catatonia de novo, report on a case: immediate vital prognosis and psychiatric prognosis in longer term].
    Patry L; Guillem E; Pontonnier F; Ferreri M
    Encephale; 2003; 29(1):72-9. PubMed ID: 12640330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suicidal and homicidal behaviors related to dextromethorphan abuse in a middle-aged woman.
    Modi D; Bhalavat R; Patterson JC
    J Addict Med; 2013; 7(2):143-4. PubMed ID: 23388679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dextromethorphan abuse masquerading as a recurrent seizure disorder.
    Majlesi N; Lee DC; Ali SS
    Pediatr Emerg Care; 2011 Mar; 27(3):210-1. PubMed ID: 21378523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013.
    Institóris L; Árok Z; Seprenyi K; Varga T; Sára-Klausz G; Keller É; Tóth RA; Sala L; Kereszty É; Róna K
    Forensic Sci Int; 2015 Mar; 248():181-6. PubMed ID: 25671307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cotrimoxazole-induced psychosis: a case report and review of literature.
    Weis S; Karagülle D; Kornhuber J; Bayerlein K
    Pharmacopsychiatry; 2006 Nov; 39(6):236-7. PubMed ID: 17124650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).
    Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI;
    Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychotic disorders related with chronic use of mephedrone. Case report].
    Urban M; Rudecki T; Wróblewski D; Rabe-Jabłońska J
    Psychiatr Pol; 2011; 45(3):431-7. PubMed ID: 22232972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection following treatment of mandible fractures: the role of immunosuppression and polysubstance abuse.
    Senel FC; Jessen GS; Melo MD; Obeid G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jan; 103(1):38-42. PubMed ID: 17178492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems.
    Kumar S; Rao PS; Earla R; Kumar A
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):343-55. PubMed ID: 25539046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).
    Wood DM; Dargan PI
    Clin Toxicol (Phila); 2012 Sep; 50(8):727-32. PubMed ID: 22882169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychoactive substances in seriously injured drivers in Denmark.
    Wiese Simonsen K; Steentoft A; Bernhoft IM; Hels T; Rasmussen BS; Linnet K
    Forensic Sci Int; 2013 Jan; 224(1-3):44-50. PubMed ID: 23142064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Is It Her Hormones?": Psychiatric Diagnoses and Polycystic Ovarian Syndrome.
    Genovese A; Smith T; Kramer H; Augustyn M
    J Dev Behav Pediatr; 2016 Jan; 37(1):103-4. PubMed ID: 26703328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
    Heikman P; Sundström M; Pelander A; Ojanperä I
    Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicology and management of novel psychoactive drugs.
    Kersten BP; McLaughlin ME
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent changes in the clinical features of patients with new psychoactive-substances-related disorders in Japan: Comparison of the Nationwide Mental Hospital Surveys on Drug-related Psychiatric Disorders undertaken in 2012 and 2014.
    Matsumoto T; Tachimori H; Takano A; Tanibuchi Y; Funada D; Wada K
    Psychiatry Clin Neurosci; 2016 Dec; 70(12):560-566. PubMed ID: 27527499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS.
    Sundström M; Pelander A; Simojoki K; Ojanperä I
    Drug Test Anal; 2016 Jan; 8(1):39-45. PubMed ID: 26017246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.